Assignee
MOMENTA PHARMACEUTICALS INC
US·83 granted patents·96 pending applications·672 citations·filing 2003–2025
Top patents by PatentIndex Score
179 records- 0198US10144944B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Dec 4, 2018·42 cites·23 claims
- 0298US9663810B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·57 cites·24 claims
- 0397US9926583B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 27, 2018·42 cites·36 claims
- 0497US9217168B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Dec 22, 2015·68 cites·28 claims
- 0597US8956830B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Feb 17, 2015·58 cites·57 claims
- 0696US9487810B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2014·Granted Nov 8, 2016·48 cites·69 claims
- 0796US8852889B2Cell culture processMOMENTA PHARMACEUTICALS INC·Filed 2014·Granted Oct 7, 2014·22 cites·30 claims
- 0895US8703498B2Multi-dimensional chromatographic methods for separating N-glycansMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted Apr 22, 2014·19 cites·28 claims
- 0994US10676526B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Jun 9, 2020·9 cites·19 claims
- 1094US7884187B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2010·Granted Feb 8, 2011·15 cites·14 claims
- 1193US7575886B2Analysis of sulfated polysaccharidesMOMENTA PHARMACEUTICALS INC·Filed 2003·Granted Aug 18, 2009·68 cites·69 claims
- 1292US11623964B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Apr 11, 2023·6 cites·7 claims
- 1392US11220531B2Engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted Jan 11, 2022·6 cites·5 claims
- 1492US11155640B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Oct 26, 2021·6 cites·2 claims
- 1592US11124573B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Sep 21, 2021·6 cites·40 claims
- 1692US10239944B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·13 cites·24 claims
- 1791US7790466B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Sep 7, 2010·15 cites·8 claims
- 1890US12360119B2Methods related to biologicsMOMENTA PHARMACEUTICALS INC·Filed 2023·Granted Jul 15, 2025·1 cites·14 claims
- 1990US8592142B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2012·Granted Nov 26, 2013·5 cites·19 claims
- 2090US2025115940A1Cell culture processMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 2189US11352415B2Methods for the treatment of neurodegenerationMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Jun 7, 2022·4 cites·5 claims
- 2289US9890410B2N-acetylhexosamine-containing N-glycans in glycoprotein productsMOMENTA PHARMACEUTICALS INC·Filed 2015·Granted Feb 13, 2018·7 cites·34 claims
- 2388US9677105B2Methods of cell cultureMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jun 13, 2017·7 cites·24 claims
- 2488US8361705B2Characterization of N-glycans using exoglycosidasesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Jan 29, 2013·14 cites·13 claims
- 2588US7816144B1Evaluating mixtures of low molecular weight heparins by chain profiles or chain mappingMOMENTA PHARMACEUTICALS INC·Filed 2009·Granted Oct 19, 2010·10 cites·7 claims
- 2687US11345751B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted May 31, 2022·4 cites·40 claims
- 2787US8921116B2Methods of evaluating diethylamide in peptide mixtures for the preparation of glatiramer acetateMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Dec 30, 2014·5 cites·7 claims
- 2886US11661456B2Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted May 30, 2023·4 cites·4 claims
- 2985US11719704B2Methods related to biologicsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Aug 8, 2023·3 cites·15 claims
- 3085US10464996B2Methods for the treatment of neurodegenerationMOMENTA PHARMACEUTICALS INC·Filed 2014·Granted Nov 5, 2019·7 cites·6 claims
- 3185US9663581B2Modified glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted May 30, 2017·7 cites·15 claims
- 3285US2024141401A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3385US2024167069A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3484US7968082B1Evaluating mixtures of low molecular weight heparins by NMRMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Jun 28, 2011·24 cites·21 claims
- 3584US2025011432A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3684US2024279703A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3783US11732047B2FcRn antibodies and methods of use thereofMOMENTA PHARMACEUTICALS INC·Filed 2020·Granted Aug 22, 2023·1 cites·26 claims
- 3883US9085796B2Analysis of amino acid copolymer compositionsMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Jul 21, 2015·4 cites·20 claims
- 3983US8043863B2MS methods to evaluate glycansMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Oct 25, 2011·14 cites·20 claims
- 4083US7947507B2Analysis of sulfated polysaccharidesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted May 24, 2011·4 cites·9 claims
- 4182US10584365B2Cell culture processMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted Mar 10, 2020·1 cites·16 claims
- 4281US9448147B2Multi-dimensional chromatographic methods for separating N-glycansMOMENTA PHARMACEUTICALS INC·Filed 2013·Granted Sep 20, 2016·2 cites·20 claims
- 4381US7811827B2Methods and apparatus for characterizing heparin-like glycosaminoglycan mixturesMOMENTA PHARMACEUTICALS INC·Filed 2008·Granted Oct 12, 2010·8 cites·39 claims
- 4481US2024067757A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4579US12297256B2Methods for the treatment of neurodegenerationMOMENTA PHARMACEUTICALS INC·Filed 2022·Granted May 13, 2025·0 cites·16 claims
- 4679US2024209040A1ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 4778US12163951B2Methods for predicting response to treatmentMOMENTA PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·0 cites·10 claims
- 4878US9933432B2Multi-dimensional chromatographic methods for separating N-glycansMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Apr 3, 2018·1 cites·22 claims
- 4978US2024158508A1FcRn Antibodies and Methods of Use ThereofMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 5077US7767420B2Heparan sulfate glycosaminoglycan lyase and uses thereofMOMENTA PHARMACEUTICALS INC·Filed 2005·Granted Aug 3, 2010·2 cites·9 claims
Showing the top 50 of 179 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when MOMENTA PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →